Related Experiment Video
Updated: Jul 17, 2026

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
Published on: March 17, 2020
[Pleomorphic Invasive Lobular Carcinoma Developed after Surgery for Simultaneous Ipsilateral Multiple Cancers]
Kenichi Sakurai1, Shuhei Suzuki, Keita Adachi
1Dept. of Breast and Endocrine Surgery, Nippon Dental University Hospital.
Abstract:
We report a case of pleomorphic invasive lobular carcinoma that developed after surgery for multiple ipsilateral cancers. The patient was a 54-year-old woman who visited our hospital after a tumor-like lesion was noted in her right breast. A needle biopsy revealed that the patient had invasive ductal carcinoma. No obvious distant metastasis was found;therefore, circular mastectomy and axillary lymph node dissection were performed. Histopathological examination revealed the following tumors;Tumor 1:Invasive ductal carcinoma(solid type), tumor diameter 33 mm, ER negative, PgR negative, HER2 negative, Ki-67 20.4%;and Tumor 2:Invasive lobular carcinoma, tumor diameter 6 mm, ER negative, PgR negative, HER2 negative, Ki-67 30.2%. The resection margin was negative, and lymph node metastasis was diagnosed as 3/12. Postoperative chemotherapy, radiation therapy, and endocrine therapy were performed. One year and 6 months after surgery, a hard lump was found in the remaining breast, and a needle biopsy confirmed it as pleomorphic lobular carcinoma. A pectoral muscle- sparing mastectomy was performed. Pathological examination of the excised specimen revealed new breast cancer:a pleomorphic lobular carcinoma, with tumor diameter 22 mm, and multiple daughter nodules. The resection margins were negative. The results were ER negative, PgR positive, HER2 negative, and Ki-67 25%. As the prognosis and treatment of invasive lobular carcinoma was unclear, caution was required.
More Related Videos
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
08:15A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...